Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Capital Expenditures (2020 - 2025)

Beauty Health (SKIN) has disclosed Capital Expenditures for 6 consecutive years, with $27000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Capital Expenditures rose 575.0% to $27000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $238000.0, a 66.48% decrease, with the full-year FY2024 number at $756000.0, down 80.24% from a year prior.
  • Capital Expenditures was $27000.0 for Q3 2025 at Beauty Health, down from $92000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $6.3 million in Q4 2021 to a low of $4000.0 in Q3 2024.
  • A 5-year average of $1.4 million and a median of $344000.0 in 2024 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: surged 2768.67% in 2022, then crashed 97.7% in 2024.
  • Beauty Health's Capital Expenditures stood at $6.3 million in 2021, then tumbled by 84.76% to $967000.0 in 2022, then crashed by 97.1% to $28000.0 in 2023, then surged by 164.29% to $74000.0 in 2024, then plummeted by 63.51% to $27000.0 in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Capital Expenditures are $27000.0 (Q3 2025), $92000.0 (Q2 2025), and $45000.0 (Q1 2025).